Piramal Pharma acquires controlling 40 per cent stake in Yapan Bio
August 19, 2026 | 11:51
Healthcare firm Piramal Pharma completed its purchase of an additional 40 per cent stake in CDMO Yapan Bio on 19 August 2026 to expand vaccine manufacturing.
Mobile Version